1 Number Every Teladoc Investor Should Pay Attention To

Investors love revenue growth. When sales are climbing rapidly, shareholders can imagine industries conquered, legacy competitors vanquished, and a future filled with profits after the company matures.

But all growth isn not created equal. Revenue might climb from acquiring new customers, selling new things to old customers, or simply raising prices. The best businesses are able to combine all three. For Teladoc Health (NYSE: TDOC), one of these growth levers appears to be slowing, and management is pointing to another one as a way to keep expanding the top line. For shareholders, that number could determine how Wall Street treats the stock over the next year.

Image source: Getty Images.

Source Fool.com